Recursion Pharmaceuticals Inc (RXRX)

NASDAQ · Biotechnology

4.03
-0.21 (-4.95%)
Updated Nov 2, 2:02 AM ET
AI Rating
Buy
Overall Score
70
Trend
100
Momentum
65
Risk
28

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Oct 20, 2025 260 sessions Oct 30, 2026

AI Analysis

Recursion Pharmaceuticals Inc is trading at $4.03, down 4.95% on the session. The 50 day average sits at $3.74 and the 200 day at $3.53, which puts the stock in a uptrend. RSI is at 52.6, which reads as neutral, and MACD is bullish crossover. Volume is below average.

The nearest support is around $3.79 with resistance near $4.16, so that band frames the current range. Average daily movement is roughly $0.36, or about 8.9% of the share price, which is what any stop placement has to allow for. The overall health score of 70 out of 100 combines a trend score of 100, momentum of 65 and a risk score of 28.

Technical indicators

RSI (14)
52.6
neutral
MACD
0.068
bullish crossover
SMA 20
3.99
SMA 50
3.74
SMA 200
3.53
uptrend
ATR (14)
0.36
avg daily range
Support
3.79
Resistance
4.16
Volume vs 20d
0.78x
below average
Volatility
124.1%
annualised
1 month
-0.98%
3 months
+26.73%

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.